Vertex Pharmaceuticals IncVRTX:NSQ

3.29 / 3.44%
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Jul 30 2014 16:06 BST.


As of last trade Vertex Pharmaceuticals Inc (VRTX:NSQ) traded at 92.27, 7.49% below its 52-week high of 99.74, set on Jul 11, 2014.

52-week range
Nov 12 2013
Jul 11 2014
Markit short selling activity
Day high95.24
Day low91.61
Previous close95.56
Average volume1.51m
Shares outstanding236.19m
Free float234.99m
P/E (TTM)--
Market cap22.57bn USD
EPS (TTM)-1.6062 USD
As of Jul 30 2014 16:06 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Vertex Pharmaceuticals Inc-5.76%-2.32%+17.34%+12.91%+156.26%
S&P 500 INDEX-0.86%+0.50%+11.03%+16.84%+99.64%
USA/HEALTH CARE-0.40%+1.72%+8.81%+17.79%--
Data delayed at least 15 minutes, as of Jul 30 2014 15:52 BST.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.